Nanotechnology for bone materials

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 1, Issue 3, 2009, Pages 336-351

  Tran, Nhiem ^a   Webster, Thomas J ^a  

^a Brown University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DISEASE; BONE IMPLANT; BONE MATERIALS; BONE-FORMING CELLS; MAGNETIC NANO-PARTICLES; NANOSTRUCTURED METALS; ORTHOPEDIC APPLICATIONS; OSSEOINTEGRATION;

NANOSTRUCTURED MATERIALS; NANOTECHNOLOGY;

BONE;

NANOMATERIAL;

BONE DEVELOPMENT; BONE PROSTHESIS; BONE REGENERATION; CHEMISTRY; NANOTECHNOLOGY; REVIEW; TISSUE ENGINEERING; TISSUE REGENERATION; ULTRASTRUCTURE;

BONE SUBSTITUTES; GUIDED TISSUE REGENERATION; NANOSTRUCTURES; NANOTECHNOLOGY; OSSEOINTEGRATION; OSTEOGENESIS; TISSUE ENGINEERING;

EID: 77949330815     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.23     Document Type: Article

References (157)

1. Liu Q. Tissue engineering. In: Shi D, ed. Biomaterials and Tissue Engineering. Verlag Berlin Heidenberg: Springer; 2004, 219.
2. Smith R. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Public Health Service, Office of the Surgeon General; 2004, 68-70.
3. http://www.niams.nih.gov/Health Info/Bone/Osteo porosis/default.asp. Accessed July 2008.
4. Webster TJ. Nanophase ceramics as improved bone tissue engineering materials. Am Ceram Soc Bull 2003, 82(6):23-28.
5. Buser D, Nydegger T, Oxland T, Cochran DL, Schenk RK, et al.: Interface shear strength of titanium implants with a sanblasted and acid-etched surface: a biomechanical study in the maxilla of miniature pigs. J Biomed Mater Res 1999, 45:75.
6. Webster TJ. Nanophase ceramics: the future of orthopedic and dental implant material. In: Ying JY, ed. Nanostructured Materials. New York: Academy Press; 2001, 125-166.
7. Kaplan FS, Hayes WC, Keaveny TM, Boskey A, Einhorn TA. Biomaterials. In: Simon SP, ed. Orthopedic Basic Science. Columbus, OH: American Academy of Orthopedic Surgeons; 1994, 460-478.
8. Daniels AU, Chang MKO, Andriano KP. Mechanical properties of biodegradable polymers and composites proposed for internal fixation of bone. J Appl Biomater 1990, 1:57.
9. Terjesen T, Apalset K. The influence of different degrees of stiffness of fixation plates on experimental bone healing. J Orthop Res 1988, 6:292.
10. Webster TJ, Siegel RW, Bizios R. Osteoblast adhesion on nanophase ceramics. Biomaterials 1999, 20(13):1221-1227.
11. Webster TJ, Siegel RW, Bizios R. Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials 2000, 21(17):1803-1810.
12. Liu H, Webster TJ. Bioinspired nanocomposites for orthopedic applications. In: Webster TJ, ed. Nanotechnology for the Regeneration of Hard and Soft Tissues. Singapore: World Scientific; 2007, 3.
13. Wang M. Developing bioactive composite materials for tissue replacement. Biomaterials 2003, 24:2133-2151.
14. Small IA, Misiek D. A sixteen-year evaluation of the mandibular staple bone plate. J Oral Maxillofac Surg 1986, 44(60):60-66.
15. McKee GK. Total hip replacement-past, present and future. Biomaterials 1982, 3:130-135.
16. Steflik DE, Sisk AL, Parr GR, Gardner LK, Hanes PJ, Lake FT, Berkery DJ, Brewer P. Osteogenesis at the dental implant interface :High-voltage electronmicroscopic and conventional transmission electron microscopic observations. J Biomed Mater Res 1993, 27:791.
17. Black J. Biological Performance of Materials. New York: Marcel Dekker; 1981.
18. Sinibaldi K, Rosen H, Lin SK, De Angelis M. Tumors associated with metallic implants in animals. Clin Orthop Relat Res 1976, 118:257-266.
19. de Oliveira PT, Nanci A. Nanotexturing of titaniumbased surfaces upregulates expression of bone sialoprotein and osteopontin by cultured osteogenic cells. Biomaterials 2004, 25:403-413.
20. Webster TJ, Ejiofor JU. Increased osteoblast adhesion on nanophase metals Ti, Ti6Al4V, and CoCrMo. Biomaterials 2004, 25(19):4731-4739.
21. Yao C, Perla V, McKenzie JL, Slamovich EB, Webster TJ. Anodized Ti and Ti6AlV possessing nanometer surface features enhance osteoblast adhesion. J Biomed Nanotechnol 2005, 1(1):68-73.
22. Sirivisoot S, Yao C, Xiao X, Sheldon BW, Webster TJ. Greater osteoblast functions on multiwalled carbon nanotubes grown from anodized nanotubular titanium for orthopedic applications. Nanotechnology 2007, 18:365102.
23. Chung TW, Liu DZ, Wang SY, Wang SS. Enhancement of the growth of human endothelial cells by surface roughness at nanometer scale. Biomaterials 2003, 24:4655-4661.
24. Kunzler TP, Drobek T, Schuler M, Spencer ND. Systematic study of osteoblast and fibroblast response to roughness by means of surface morphology gradients. Biomaterials 2007, 28:2175-2182.
25. Zhao G, Raines AL, Wieland M, Schwartz Z, Boyan BD. Requirement for both micron- and submicron scale structure for synergistic responses of osteoblasts to substrate surface energy and topography. Biomaterials 2007, 28:2821-2829.
26. Dyer MA, Ainslie KM, Pishko MV. Protein adhesion on siliconsupported hyperbranched poly(ethylene glycol) and poly(allylamine) thin films. Langmuir 2007, 23:7018-7023.
27. Khang D, Lu J, Yao C, Haberstroh KM, Webster TJ. The role of nanometer and sub-micron surface features on vascular and bone cell adhesion on titanium. Biomaterials 2008, 29:970.
28. Hayashi H, Uchida A, Hamada H, Yoshikawa H, Shinto Y, et al.: Alumina ceramic prostheses for bone reactions to alumina oxide dental implants in man: a case report. Arch Orthop Trauma Surg 1992, 112:1-4.
29. Davies JE, Matsuda T. Extracellular matrix production by osteoblasts on bioactive substrate in vitro. Scanning Microsc 1988, 2(1445)52.
30. Sautier JM, Nefussi JR, Forest N. Ultrasonic study of bone formation on synthetic hydroxyapatite in osteoblasts cultures. Cell Mater 1991, 1209-217.
31. Matsuda T, Davies JE. The in vitro response of osteoblasts to bioactive glass. Biomaterials 1987, 8275-285.
32. LeGeros RZ Calcium Phosphates in Oral Biology and Medicine. Basel Karger; 1991.
33. Kokubo T, Ito S, Huang T, Sakka S, Kitsugi T, et al. P-rich layer formed on high-strength bioactive glassceramic A-W. J BiomedMaterRes 1990, 24331-343.
34. Nagano M, Nakamura T, Kokubo T, Tanahashi M, Ogawa M. Differences of bone bonding ability and degradation behavior in vivo between amorphous calcium phosphate and highly crystalline hydroxylapatite coating. Biomaterials 1996, 171771-1777.
35. Webster TJ, Schadler LS, Siegel RW, Bizios R. Mechanisms of enhanced osteoblast adhesion on nanophase alumina involve vitronectin. Tissue Eng 2001, 7291-301.
36. Webster TJ, Siegel RW, Bizios R. Specific proteins mediate osteoblast adhesion on nanophase ceramics. J BiomedMater Res 2000, 51475.
37. Agrawal CM, Ray RB. Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J Biomed Mater Res 2001, 55(2)141-150.
38. Balasundaram G, Webster TJ. An overview of nanopolymers for orthopedic applications. Macromol Biosci 2007, 7635-642.
39. Rodrigues CVM, Serricella P, Linhares ABR, Guerdes RM, Borojevic R, et al. Characterization of a bovine collagen-hydroxyapatite composite scaffold for bone tissue engineering. Biomaterials 2003, 24(27)4987-4997.
40. Dunn MG, Bellincampi LD, Tria AJ, Zawadsky JP. Preliminary development of a collagen-PLA composite for ACL reconstruction. J Appl Polym Sci 1997, 63(11)1423-1428.
41. Liao SS, Cui FZ, Zhu Y. Osteoblast adherence and migration through three-dimensional porous mineralized collagen based composite nHAC/PLA. J Bioact Compat Polym 2004, 19(2)117-130.
42. Liu H, Webster TJ. Bioinspired nanocomposites for orthopedic applications. In Webster TJ ed. Nanotechnology for the Regeneration of Hard and Soft Tissues Singapore World Scientific; 2007, 24.
43. Liu Q. Tissue engineering. In Shi D, ed. Biomaterials and Tissue Engineering. Berlin/Heidenberg Springer; 2004, 200.
44. Chen VJ, Ma PX. Nano-fibrous poly(L-lactic acid) scaffolds with interconnected spherical macropores. Biomaterials 2004, 25(11)2065-2073.
45. Karp JM, Shoichet MS, Davies JE. Bone formation on two-dimensional poly(DL-lactide-co-glycolide) (PLGA) films and three-dimensional PLGA tissue engineering scaffolds in vitro. J BiomedMaterRes A 2003, 64(2)388-396.
46. Liu X, Ma PX. Polymeric scaffolds for bone tissue engineering. Ann Biomed Eng 2004, 32(3)477-486.
47. Wei G, Ma PX. Structure and properties of nano-hydroxyapatite/polymer composite scaffolds for bone tissue engineering. Biomaterials 2004, 25(19)4749-4757.
48. Thapa A, Miller DC, Webster TJ. Nano-structured polymers enhance bladder smooth muscle cell function. Biomaterials 2003, 242915.
49. Price RL, Ellison K, Haberstroh KM, Webster TJ. Nanometer surface roughness increases select osteoblast adhesion on carbon nanofiber compacts. J BiomedMater Res 2004, 70129.
50. Price RL, Gutwein LG, Kaledin L, Tepper F, Webster TJ. Osteoblast function on nanophase alumina materials influence of chemistry, phase, and topography. J Biomed Mater Res 2003, 671284.
51. Webster TJ, Waid MC, McKenzie JL, Price RL, Ejiofor JU. Nano-biotechnology carbon nanofibers as improved neural and orthopaedic implants. Nanotechnology 2004, 1548.
52. Boccaccini AR, Maquet V. Bioresorbable and bioactive polymer/bioglass composites with tailored pore structure for tissue engineering applications. Compos Sci Technol 2003, 632417-2429.
53. Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000, 212529-2543.
54. Thomson RC, Yaszemski MJ, Powers JM, Mikos AG. Hydroxyapatite fiber reinforced poly(a- hydroxy ester) foams for bone regeneration. Biomaterials 1998, 191935-1943.
55. Kikuchi M, Itoh S, Ichinose S, Shinomiya K, Tanaka J. Self-organization mechanism in a bone-like hydroxyapaptite/collagen nanocomposite synthesized in vitro and its biological reaction in vivo. Biomaterials 2001, 221705-1711.
56. Christenson EM, Anseth KS, van den Beucken JJ, Chan CK, Ercan B, et al. Nanobiomaterial applications in orthopedics. J Orthop Res 2007, 25(1)11-22.
57. Liu H, Slamovich EB, Webster TJ. Increased osteoblast functions on nanophase titania dispersed in poly-lactic-co-glycolic acid composites. Nanotechnology 2005, 16S601-S608.
58. Du C, Cui FZ, Zhu XD, de Groot K. Threedimensional nano-HAP/collagen matrix loading with osteogenic cells in organ culture. J BiomedMater Res 1999, 44407-415.
59. Du C, Cui FZ, Feng QL, Zhu XD, de Groot K. Tissue response to nano-hydroxyapatite/collagen composite implants in marrow cavity. J BiomedMaterRes 1998, 42540-548.
60. Boccaccini AR, Roether JA, Hench LL, Maquet V, Jerome R. A composite approach to tissue engineering. Ceram Eng Sci Proc 2002, 23(4)805-816.
61. Marra KG, Szem JW, Kumta PN, Di Milla PA, Weiss LE. In vitro analysis of biodegradable polymer blend/hydroxyapatite composites for bone tissue engineering. J BiomedMater Res 1999, 47(3)324-335.
62. Kalita S, Finley J, Bose S, Hosick H, Bandyopadhyay A. Development of porous polymer-ceramic composites as bone grafts. Mater Res Soc Symp Proc 2002, 72691-96.
63. Blaker JJ, Gough JE, Maquet V, Notingher I, Boccaccini AR. In vitro evaluation of novel bioactive composites based on bioglass-filled polylactide foams for bone tissue engineering scaffolds. J BiomedMaterRes A 2003, 67(4)1401-1411.
64. Ma PX, Zhang R, Xiao G, Franceschi R. Engineering new bone tissue in vitro on highly porous poly(ahydroxyl acids)/hydroxyapatite composite scaffolds. J Biomed Mater Res 2001, 54(2)284-293.
65. Jung Y, Kim SS, Kim YH, Kim SH, Kim BS, et al. A poly(lactic acid)/calcium metaphosphate composite for bone tissue engineering. Biomaterials 2005, 266314-6322.
66. Smith TA, Webster TJ. Increased osteoblast function on PLGA composites containing nanophase titania. J Biomed Mater Res 2005, 74A677-686.
67. McManus AJ, Doremus RH, Siegel RW, Bizios R. Evaluation of cytocompatibility and bending modulus of nanoceramic/polymer composites. J Biomed Mater Res A 2005, 72(1)98-106.
68. Moghimi SM, Hunter ACH, Murray JC. Longcirculating and target-specific nanoparticles theory to practice. Pharmacol Rev 2001, 53283-318.
69. Curtis ASG, Wilkinson C. Nanotechniques and approaches in biotechnology. Trends Biotechnol 2001, 1997-101.
70. Wilkinson JM. Nanotechnology applications in medicine. Med Device Technol 2003, 14(5)29-31.
71. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003, 55329-347.
72. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 263995-4021.
73. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, et al. Characterization of biophysical and metabolicproperties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 2003, 229(3)838-846.
74. Reimer P, Weissleder R. Development and experimental application of receptor-specific MR contrast media. Radiology 1996, 36153-163.
75. Pankhurst QA, Connolly J, Jones SK, Dobson J. Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 2003, 36R167-R181.
76. Hafeli U, Schutt W, Teller J, Zborowski M, eds. Scientific and Clinical Applications of Magnetic Carriers. New York Plenum Press; 1997.
77. Harris LA. Polymer Stabilized Magnetite Nanoparticles and Poly(propylene oxide) Modified Styrenedimethacrylate Networks. Doctor of Philosophy dissertation, Virginia Polytechnic Institute and State University, Virginia, 2002, 29.
78. Gilchrist RK, Medal R, Shorey WD, Hanselman RC, Parrot JC, et al. Selective inductive heating of lymph nodes. Ann Surg 1957, 146596-606.
79. Schwertmann U, Cornell RM. Iron Oxides in the Laboratory Preparation and Characterization. Weinheim VCH; 1991.
80. Oliveira DM, Lacava ZGM, Lima ECD, Morais PC, Tedesco AC. Zinc phthalocyanine/magnetic fluid complex a promising dual nanostructured system for cancer treatment. J Nanosci Nanotechnol 2006, 62432-2437.
81. Thünemann AF, Schütt D, Kaufner L, Pison U, Möhwald H. Maghemite nanoparticles protectively coated with poly(ethylene imine) and poly(ethylene oxide)-block-poly(glutamic acid). Langmuir 2006, 222351-2357.
82. Hamley IW. Nanotechnology with soft materials. Angew Chem Int Ed 2003, 421692-1712.
83. Tepper T, Ilievski F, Ross CA, Zaman TR, Ram RJ, et al. Magneto-optical properties of iron oxide films. J Appl Phys 2003, 93(10)6948-6950.
84. Berry CC, Curtis ASG. Functionalisation of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys 2003, 36R198-R206.
85. Papell SS, Faber OC. On the influence of nonuniform magnetic fields on ferromagnetic colloidal sols. NASA Technical Note, Vol. (NASA-TN-D-4676), 1968, 25.
86. Stolnik S, Illum L, Davis SS. Long circulating microparticulate drug carriers. Adv Drug Deliv Rev 1995, 16195-214.
87. Kodas TT, Hampden-Smith M Aerosol Processing of Materials. New York Wiley-VCH; 1999.
88. Lee CS, Lee H, Westervelt RM. Microelectromagnets for the control of magnetic nanoparticles. Appl Phys Lett 2001, 79(20)3308-3310.
89. RishtonA, LuY, AltmanRA, MarleyAC, Bian Hahnes C, et al. Magnetictunnel junctions fabricated at tenth-micron dimensions by electron beam lithography. Microelectron Eng 1997, 35249.
90. Sidhu PS, Gilkes RJ, Posner AM. The synthesis and some properties of Co, Ni, Zn, Cu, Mn and Cd substituted magnetites. J Inorg Nucl Chem 1978, 40429-437.
91. Strable E, Bulte JWM, Moskowitz B, Vivekanandan K, Allen M, et al. Synthesis and characterization of soluble iron oxide-dendrimer composites. Chem Mater 2001, 132201.
92. Cornell RM, Schertmann U. Iron Oxides in the Laboratory; Preparation and Characterization.Weinheim VCH; 1991.
93. Lee KM, Sorensen CM, Klabunde KJ, Hadjipanayis GC. Synthesis and characterization of stable colloidal Fe/sub 3/O/sub 4/ particles in water-in-oil microemulsions. IEEE Trans Magn 1992, 283180.
94. Dresco PA, Zaitsev VS, Gambino RJ, Chu B. Preparation and properties of magnetite and polymer magnetite nanoparticles. Langmuir 1999, 151945.
95. O'Connor CJ, Seip C, Sangregorio C, Carpenter E, Li S, Irvin G, John VT. Mol Cryst Liq Cryst 1999, 335423-442.
96. Lopez-Perez JA, Lopez-Quintela MA,Mira J, Rivas J. Preparation of magnetic fluids with particles obtained in microemulsions. IEEE TransMagn 1997, 334359.
97. Santra S, Tapec R, Theodoropoulou N, Dobson J, Hebard R, Tan W. Synthesis and characterization of silica-coated iron oxide nanoparticles in microemulsion The effect of nonionic surfactants. Langmuir 2001, 172900-2906.
98. Yaacob II, Nunes AC, Bose A. Magnetic nanoparticles produced in spontaneous cationic-anionic vesicles room temperature synthesis and characterization. J Colloid Interface Sci 1995, 17173.
99. Meldrum FC, Heywood BR, Mann S. Magnetoferritin in vitro synthesis of a novel magnetic protein. Science 1992, 257522.
100. Harrison PM, Arosio P. The ferritinsmolecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996, 1275161.
101. Wong KKW, Douglas T, Gider S, Awschalom DD, Mann S. Biomimetic synthesis and characterization of magnetic proteins (magnetoferritin). Chem Mater 1998, 10279.
102. Sangregorio C, Wiemann JK, O'Connor CJ, Rosenzweig Z. A new method for the synthesis of magnetoliposomes. J Appl Phys 1999, 855699.
103. Bulte JWM, de Cuyper M, Despres D, Frank JA. Preparation, relaxometry, and bio kinetics of PEGylated magneto liposomes as MR contrast agent. J Magn Magn Mater 1999, 194204-209.
104. Molday RS, MacKenzie D. Immuno specific ferro magnetic iron-dextron reagents for the labeling and magnetic separation of cells. J Immunol Methods 1982, 52353-367.
105. Kim DK, Zhang Y, Kehr J, Klason T, Bjelke B, et al.. Characterization and MRI study of surfactant-coated superparamagnetic nanoparticles administered into the rat brain. J Magn Magn Mater 2001, 225256.
106. Pardoe H, Chua-anusorn W, St. Pierre TG, Dobson J. Structural and magnetic properties of nanoscale iron oxide particles synthesized in the presence of dextran or polyvinyl alcohol. J Magn Magn Mater 2001, 22541.
107. Lee J, Isobe T, Senna M. Preparation of ultrafine Fe3O4 particles by precipitation in the presence of PVA at high pH. J Colloid Interface Sci 1996, 177490.
108. Mendenhall GD, Geng Y, Hwang J. Optimization of long-term stability of magnetic fluids from magnetite and synthetic polyelectrolytes. J Colloid Interface Sci 1996, 184519.
109. Ding XB, Sun ZH, Wan GX, Jiang YY. Preparation of thermosensitive magnetic particles by dispersion polymerization. React Funct Polym 1998, 3811.
110. Dumazet-Bonnamour I, Le Perchec P. Colloidal dispersion of magnetite nanoparticles via in situ preparation with sodium polyoxyalkylene di-phosphonates. Colloids Surf A 2000, 17361.
111. Tamaura Y, Takahasi K, Kodera Y, Saito Y, Inada Y. Chemical modification of lipase with ferromagnetic modifier - A ferro magnetic - modified lipase. Biotechnol Lett 1986, 8877-880.
112. Wormuth K. Superparamagnetic latex via inverse emulsion polymerization. J Colloid Interface Sci 2001, 241366.
113. Blum E, Cebers A, Maiorov MM. Magnetic Fluids. Berlin Walter de Gruyter; 1997.
114. Sato T, Iijima T, Sekin M, Inagaki N.Magnetic properties of ultrafine ferrite particles. JMagn Magn Mater 1987, 65252-256.
115. Zins D, Cabuil V, Massart R. New aqueous magnetic fluids. J Mol Liq 1999, 83217.
116. Goetze T, Gansau C, Buske N, Roeder M, Gornent P, Bahr M. Bio compatible magnetic core/shell nanoparticles. J Magn Magn Mater 2002, 252399-402.
117. Elmore WC. Ferromagnetic colloid for studying magnetic structures. Phys Rev 1938, 54309.
118. Bacri J, Perzynski R, Salin D, Cabuil V, Massart R. Ionic ferrofluids a crossing of chemistry and physics. J Magn Magn Mater 1990, 8527.
119. Massart R. Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE TransMagn 1981, 171247.
120. Shen L, Laibinis P, Hatton TA. Bilayer surfactant stabilized magnetic fluids synthesis and interactions at interfaces. Langmuir 1999, 15447.
121. Gribanov NM, Bibik EE, Buzunov OV, Naumov VN. Physico-chemical regularities of obtaining highly dispersed magnetite by the method of chemical condensation. J Magn Magn Mater 1990, 857.
122. Wu KT, Kuo PC, Yao YD, Tsai EH. Magnetic and optical properties of Fe3O4 nanoparticle ferrofluids prepared by coprecipitation techniques. IEEE Trans Magn 2001, 372651.
123. Gupta AK, Wells S. Surface modified superparamagnetic nanoparticles for drug delivery preparation, characterization and cytotoxicity studies. IEEE Trans Nanobiosci 2004, 3(1)66-73.
124. Charles SW. Magneticfluids (ferrofluids). In Dormann JL, Fiorani D, eds. Magnetic Properties of Fine Particles. North Holland Elsevier; 1992, 267-374.
125. Gupta AK, Curtis ASG. Lactoferrin and ceruloplasmin derivatized superparamagneticiron oxide nanoparticles for targeting cell surface receptors. Biomaterials 2004, 25(15)3029-3040.
126. Kim DK, Zhang Y, Voit W, Rao KV,Muhammed M. Synthesis and characterization of surfactantcoated superparamagnetic monodispersed iron oxide nanoparticles. J Magn Magn Mater 2001, 225(1-2)30-36.
127. Zimmermann U, Pilwat G. Organ specific application of drugs by means of cellular capsule systems. Z Nat C Biosci 1976, 31732-736.
128. Kato T, Nemoto R, Mori H, Abe R, Unno K, et al. Magnetic microcapsules for targeted delivery of anticancer drugs. Appl Biochem Biotechnol 1984, 10199.
129. Widder KJ, Morris RM, Poore G, Howard DP, Senyei AE. Tumor remission in yoshida sarcomabearing rats by selective targeting of magnetic albumin microspheres containing doxorubicin. Proc Natl Acad Sci USA 1981, 78579.
130. Gupta PK, Hung CT. Effect of carrier dose on the multiple tissue disposition of doxorubicin hydrochloride administered via magnetic albumin microspheres in rats. J Pharmacol Sci 1989, 78290.
131. Morimoto Y, Sughibayashi K, Okumura M, Kato Y. Biomedical applications of magnetic fluids. I. Magnetic guidance of ferro colloid entrapped albumin microspheres for site-specific drug delivery in vivo. J Pharmacobiodyn 1980, 3264.
132. Lübbe AS, Bergemann C, Huhnt W, Fricke T, Riess H, et al. Preclinical experiences with magnetic drug targeting tolerance and efficacy. Cancer Res 1996, 564694.
133. Lübbe AS, Bergemann C, Riess H, Schriever F, Reichardt P, et al. Clinical experiences with magnetic drug targeting a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res 1996, 564686.
134. Goodwin S, Peterson C, Hob C, Bittner C. Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy. J Magn Magn Mater 1999, 194132-139.
135. Goodwin SC, Bittner CA, Peterson CL, Wong G. Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier. Toxicol Sci 2001, 60177-183.
136. Alexiou C, Arnold W, Klein RJ, Parak FG, Hulin P, et al. Locoregional cancer treatment with magnetic drug targeting. Cancer Res 2000, 606641-6648.
137. Lubbe AS, Bergemann C, Brock J, McClure DG. Physiological aspects in magnetic drug-targeting. J Magn Magn Mater 1999, 194149-155.
138. Pulfer SK, Gallo JM. Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres. J Drug Target 1999, 6215-228.
139. Pulfer SK, Ciccotto SL, Gallo JM. Distribution of small magnetic particles in brain tumor-bearing rats. J Neurooncol 1999, 4199-105.
140. Pareta R, Taylor E, Webster TJ. Increased osteoblast density in the presence of novel calcium phosphate coated magnetic nanoparticles. Nanotechnology 2008, 197.
141. Kang YS, Risbud S, Rabolt JF, Stroeve P. Synthesis and characterization of nanometer-size Fe3O4 and ? -Fe2O3 particles. Chem Mater 1996, 82209-2211.
142. Arruebo M, Ferńandez-Pacheco R, Ibarra MR, Santamaŕia J. Magnetic nanoparticles for drug delivery. Nano Today 2007, 2(3)22-32.
143. Neuberger T, Schöpf B, Hofmann H, Hofmann M, von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications possibilities and limitations of a new drug delivery system. J Magn Magn Mater 2005, 293483.
144. Liu H, Webster TJ. Bioinspired nanocomposites for orthopedic applications. In Webster TJ, ed. Nanotechnology for the Regeneration of Hard and Soft Tissues World Scientific; 2007, 43.
145. Macaroff PP, Simioni AR, Lacava ZGM, Lima ECD, Morais PC, et al. Studies of cell toxicity and binding of magnetic nanoparticles with blood stream macromolecules. J Appl Phys 2006, 9908S102.
146. Park SI, Lim JH, Kim JH, Yun HI, Kim CO. Toxicity estimation of magnetic fluids in a biological test. J Magn Magn Mater 2006, 304e406.
147. Duncan R, Izzo L. Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 2005, 572215. 148. Yin H, Too HP, Chow GM. The effects of particle size and surface coating on the cytotoxicity of nickel ferrite. Biomaterials 2005, 265818.
148. Yin H, Too HP, Chow GM. The effects of particle size and surface coating on the cytotoxicity of nickel ferrite. Biomaterials 2005, 265818
149. Sunderland CJ, Steiert M, Talmadge JE, Derfus AM, Barry SE. Targeted nanoparticles for detecting and treating cancer. Drug Dev Res 2006, 6770.
150. www.alnis.com (accessed, July 2008).
151. www.chemicell.com (accessed, July 2008).
152. Liu H, Webster TJ. Bio inspired nano composites for orthopedic applications. In Webster TJ, ed. Nanotechnology for the Regeneration of Hard and Soft Tissues. World Scientific, Singapore; 2007, 4.
153. Liu Q. Tissue engineering. In Shi D, ed. Biomaterials and Tissue Engineering. Berlin Heidenberg Springer Verlag; 2004, 208.
154. Liu Q. Tissue engineering. In Shi D, ed. Biomaterials and Tissue Engineering. Berlin Heidenberg Springer Verlag; 2004, 208.
155. Ma PX. Scaffolds for tissue fabrication. Materials Today 2004, 7(5)30-40.
156. Taddei P, Monti P, Simoni R. Vibrational and thermal study on the in vitro and in vivo degradation of a poly (lactic acid) - based bioabsorbable periodontal membrane. Journal of Materials Science Materials in Medicine 2002, 13(5)469-475.
157. Balasundaram G. Nanomaterials for better orthopedics. In Webster TJ, ed. Nanotechnology for the Regeneration of Hard and Soft Tissues. World Scientific, Singapore, 2007, 72.